Hematology/Medical Oncology Fellowship Program

About Hematology/medical oncology fellowship program

The Hematology Oncology fellowship at Lankenau Medical Center is a 36-month ACGME-accredited training program. Two fellows are accepted each year for a total of six trainees. The fellowship's program size allows for a personalized learning environment with dedicated faculty members.

The fellowship strives to produce well-rounded hematology oncology physicians who can provide compassionate, patient-oriented, evidence-based care in the community setting.

The competency-based curriculum permits each fellow to increasingly gain experience in the clinical setting as a member of a multi-disciplinary team, conduct scholarly activity and ultimately be ready for unsupervised practice.

The fellowship offers extraordinary outpatient experience in the Continuity Clinic and with faculty members in Lankenau Medical Center's onsite private practice. Fellows are provided with a total of 11 months to conduct clinical or basic research alongside faculty with Lankenau Institute for Medical Research and with Main Line Health's system-wide Integrated Network Cancer Program.

Research updates in Catalyst, LIMR’s quarterly magazine

Learn more about Diversity, Respect, Equity & Inclusion at Main Line Health

Life at Lankenau Medical Center

Situated on a rolling 93-acre suburban campus in Wynnewood, Pa., Lankenau Medical Center is located west of the City of Philadelphia. As one of the flagship hospitals with Main Line Health system, Lankenau Medical Center offers the combined benefits of major metropolitan academic medical center and the hospital within a community setting.

In the Best Hospitals 2022-2023 issue of US News and World Report, Lankenau Medical Center distinguished itself as the #3 premier health care facility in the region and #6 in the state, out of the more than 200 hospitals in Pennsylvania. Lankenau Medical Center ranked in the top 50 hospitals out of more than 4,500 nationwide for OB/GYN.

How to apply

All fellowship applicant materials are submitted through the AAMC's Electronic Residency Application Service and Main Line Health and Graduate Medical Education adheres to its regulations. We consider all submitted applications, sponsor J-1 and H1B visas and remain committed to training physicians from all backgrounds.

Main Line Health and Graduate Medical Education prohibits any discrimination on the basis of race, religion, color, sex (including pregnancy, gender identity, gender expression and sexual orientation), parental status, national origin, ancestry, age, disability, political affiliation, military service, relationship status or any other classification protected by federal, state or local law. Our equal employment policy requires that decisions related to hiring, firing and promotion be based on the individual’s ability, qualifications, experience and job performance.

The following documents are required:

  • ERAS application
  • Curriculum vitae
  • Personal statement
  • Three letters of recommendation (one from current program director)
  • Medical School Dean's letter and transcript

Interview invitations will be sent out by August 23, 2024. Should you have a question not answered on this page please contact Fellowship Coordinator Kathryn Lattanzio at LattanzioK@mlhs.org.

Rotations

Hematology/medical oncology fellows serve in a number of rotations during the 36-month program. These rotations are designed to expose the fellow to a wide range of work in the medical specialties, as well as offering them work in a variety of settings.

Throughout the year, fellows will be entirely off duty at least one day out of seven when averaged over a four-week period. There is no in-house overnight call and we adhere to the ACGME requirements for an 80-hour work week.

PGY-4 rotations

Inpatient consults

Lankenau Medical Center

6 months

Outpatient oncology

Lankenau Medical Center

3 months

Pathology/blood banking

Lankenau Medical Center

1 month

Radiation oncology

Lankenau Medical Center

1 month

Subspecialty continuity clinic (LMA)

Lankenau Medical Center

½ session per week

Hemostasis & thrombosis

Thomas Jefferson University

1 month

PGY-5 rotations

Inpatient consults

Lankenau Medical Center

4 months

Outpatient oncology

Lankenau Medical Center

3 months

Surgical oncology

Lankenau Medical Center

1 month

Research

Lankenau Medical Center

2 months

Subspecialty continuity clinic (LMA)

Lankenau Medical Center

2 sessions per week

Bone marrow transplant

Thomas Jefferson University

1 month

Lymphoma/myeloma

Thomas Jefferson University

1 month

PGY-6 rotations

Inpatient consults:

Lankenau Medical Center

2 months

Outpatient oncology

Lankenau Medical Center

1 month

Research

Lankenau Medical Center

9 months

Subspecialty continuity clinic (LMA)

Lankenau Medical Center

½ session per week*

*Opportunity for another ½ session in subspecialty continuity clinic

Affiliated Main Line Health practice, upon approval from program director

 

Curriculum

The small program size and approachable attendings make for a strong, cohesive and collegial training experience and education. Our robust didactic schedule encourages greater faculty participation and provides a well rounded curriculum that includes

  • Grand rounds with national speakers, journal club, randomized clinical trials, board review sessions, basic science lecture.
  • Microscopy rounds with hematopathology, lung tumor conference, GI oncology conference, hematology oncology pathology conference and fellows’ continuity clinic review.
  • Wellness and a formal end-of-life curriculum to augment the academic medicine sessions.
  • Multidisciplinary conferences for breast, lung and hepatobiliary-pancreatic/colorectal cancers.
  • System-wide tumor work groups and conferences for breast, GI, lung and G/U cancers where fellows are encouraged to present cases.

The Fellowship curriculum provides trainees with exposure to both basic science and clinical research. This educational experience can be further individualized for fellows who wish to pursue a different career path (i.e. working for the pharmaceutical industry or in the bone marrow transplant setting). It is hoped that a meaningful research experience during fellowship will carry over into clinical practice by instilling a sense of inquiry and self.

  • Our Basic Science curriculum covers the discovery of the gene, how it works, how and why it is clinically relevant and how it’s used to guide diagnostic and therapeutic decision-making. Through this teaching, fellows will make connections between the molecules/pathways and will build a unified understanding of how cancer cells become what they are and how to treat and diagnose them.
  • The curriculum for the Lankenau Medical Center Hematology/Medical Oncology Fellowship is designed to provide trainees with the experience of treating a wide range of patients and illnesses, as well as pursuing scientific and academic knowledge and achievement. By stressing teamwork and cooperation between multiple medical disciplines, the program provides fellows the skills to work in the modern health care environment.

While Lankenau Medical Center serves as the primary training site for the Hematology Oncology Fellowship, fellows will also complete several core rotations at academic affiliate Thomas Jefferson University (TJU).

Faculty, fellows and alumni

Learn more about the Hematology/Medical Oncology Fellowship Program's faculty, fellows and alumni.

Main Line Health and Graduate Medical Education prohibits any discrimination on the basis of race, religion, color, sex (including pregnancy, gender identity, gender expression and sexual orientation), parental status, national origin, ancestry, age, disability, political affiliation, military service, relationship status or any other classification protected by federal, state or local law. Our equal employment policy requires that decisions related to hiring, firing and promotion be based on the individual’s ability, qualifications, experience and job performance.